{"id":538,"date":"2014-04-15T18:07:20","date_gmt":"2014-04-15T18:07:20","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=538"},"modified":"2014-04-15T18:07:20","modified_gmt":"2014-04-15T18:07:20","slug":"japanese-university-wrongly-disclosed-data-to-novartis-in-leukaemia-drug-study","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2014\/04\/15\/japanese-university-wrongly-disclosed-data-to-novartis-in-leukaemia-drug-study\/","title":{"rendered":"Japanese University Wrongly Disclosed Data to Novartis in Leukaemia Drug Study"},"content":{"rendered":"<p><strong>An interim report from the University of Tokyo Hospital found that Novartis inappropriately received data on patients participating in a trial of the company&#8217;s leukaemia drug Tasigna (nilotinib). &#8221; The leak is a serious breach of confidentiality as well as a violation of the Personal Information Protection Law,&#8221; hospital director Takashi Kadowaki said. The hospital added that it is unsure whether the documents had been altered.<\/strong><\/p>\n<p><strong>Senior officials at Japan&#8217;s Ministry of Health, Labour and Welfare described the case as serious and requested a detailed investigative report from the hospital. (Source: Firstwordpharma.com)<\/strong><\/p>\n<h3><\/h3>\n<h3>\u6570\u636e\u518d\u7206\u9020\u5047\uff1f\u8bfa\u534e\u5f00\u9664\u4ee8\u65e5\u672c\u9ad8\u7ba1<\/h3>\n<p>\u6765\u6e90\uff1aE\u836f\u8138\u8c31\u7f51<\/p>\n<p>\u56e0\u7206\u51fa\u5b66\u672f\u9020\u5047\u4e11\u95fb\uff0c\u8bfa\u534e\u603b\u90e8\u4e0e\u5176\u5728\u65e5\u672c\u7684\u7ba1\u7406\u56e2\u961f\u65e5\u524d\u51b3\u88c2\u3002\u5728\u7ecf\u8fc7\u4e25\u683c\u7684\u5ba1\u67e5\u4e4b\u540e\uff0c4\u67083\u65e5\uff0c\u8fd9\u5bb6\u745e\u58eb\u516c\u53f8\u5f00\u9664\u4e86\u65e5\u672c3\u540d\u53c2\u4e0e\u767d\u8840\u75c5\u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u9020\u5047\u7684\u9ad8\u5c42\u7ecf\u7406\u3002<\/p>\n<p>\u636e\u6089\uff0c\u8bfa\u534e\u7684\u9500\u552e\u4ee3\u8868\u53ca\u5176\u4ed6\u96c7\u5458\u53c2\u4e0e\u4e865\u9879\u8bc4\u4ef7\u767d\u8840\u75c5\u836f\u7269\u4e0d\u826f\u53cd\u5e94\u7684\u4e34\u5e8a\u7814\u7a76\u3002\u6839\u636e\u4e1c\u4eac\u5927\u5b66\u533b\u9662\u65b9\u9762\u7684\u8bf4\u6cd5\uff0c\u8bfa\u534e\u7684\u5458\u5de5\u88ab\u5141\u8bb8\u4ece\u5404\u79cd\u8bd5\u9a8c\u7f51\u7ad9\u641c\u96c6\u60a3 \u8005\u7684\u6570\u636e\uff0c\u540c\u65f6\u4e5f\u53c2\u4e0e\u8bb0\u5f55\u4e86255\u4e2a\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7ed3\u679c\u3002\u8be5\u7814\u7a76\u4e2d\u6d89\u53ca\u8bfa\u534e\u7684\u5c3c\u7f57\u66ff\u5c3c\uff08Tasigna\uff09\uff0c\u5176\u4f5c\u4e3a\u7a81\u7834\u6027\u6cbb\u7597\u65b9\u6cd5\u683c\u5217\u536b\u7684\u968f\u8bbf\u7814\u7a76\u3002\u5728\u8fd9\u4e9b\u5b66\u672f \u4e0d\u7aef\u884c\u4e3a\u6d6e\u51fa\u6c34\u9762\u540e\uff0c\u8c03\u67e5\u8005\u4ece\u8bfa\u534e\u56e2\u961f\u4e2d\u68c0\u67e5\u53d1\u73b0\u4e86\u5927\u91cf\u7684\u6587\u4ef6\u88ab\u7c89\u788e\u6216\u8005\u5220\u9664\u3002<\/p>\n<p>4\u67084\u65e5\uff0c\u8bfa\u534e\u53ec\u5f00\u65b0\u95fb\u53d1\u5e03\u4f1a\uff0c\u8bfa\u534e\u5168\u7403\u5236\u836f\u90e8\u95e8\u603b\u88c1David Epstein\u5bf9\u6b64\u4e8b\u8868\u793a\u516c\u5f00\u81f4\u6b49\uff1a\u201c\u4ed6\u4eec\u7684\u884c\u4e3a\u662f\u660e\u663e\u8fdd\u53cd\u884c\u4e3a\u89c4\u8303\u7684\uff0c\u662f\u4e0d\u53ef\u63a5\u53d7\u7684\u3002\u201d<\/p>\n<p>\u5728\u524d\u6b21\u201c\u4ee3\u6587\u6570\u636e\u9020\u5047\u201d\u4e8b\u4ef6\u4e2d\uff0c\u8bfa\u534e\u65e5\u672c\u9ad8\u7ba1\u88ab\u6574\u4f53\u964d\u85aa30%\u3002\u6b64\u6b21\u4e8b\u4ef6\u4e00\u51fa\uff0c\u8bfa\u534e\u9009\u62e9\u4e86\u76f4\u63a5\u5f00\u9664\u3002\u76ee\u524d\uff0c\u8bfa\u534e\u76ee\u524d\u6307\u6d3e\u5916\u7c4d\u7ecf\u7406\u63a5\u7ba1\u65e5\u672c\u529e\u516c\u5ba4\u3002\u6765 \u81ea\u82f1\u56fd\u7684\u7ecf\u7406Michael Ferris\u5c06\u53d6\u4ee3\u65e5\u672c\u7ecf\u7406Hiroko Ishikawa\u5f00\u5c55\u5de5\u4f5c\u3002\u5fb7\u56fd\u4ebaDirk Kosche\u5c06\u53d6\u4ee3Yoshiyasu Ninomiya\u6210\u4e3a\u65b0\u4efb\u65e5\u672c\u5546\u4e1a\u7ecf\u7406\uff0c \u52a0\u62ff\u5927\u4ebaFrancis Bouchard\u5c06\u53d6\u4ee3Kazuo Asakawa\u8fd0\u8425\u80bf\u7624\u836f\u4e1a\u52a1\u3002<\/p>\n<p>\u5bf9\u4e8e\u4e00\u76f4\u9971\u53d7\u6570\u636e\u9020\u5047\u4e11\u95fb\u7684\u8bfa\u534e\u6765\u8bf4\uff0c\u4ee3\u6587\u5728\u65e5\u672c\u7684\u9500\u552e\u989d\u5df2\u7ecf\u4e0b\u964d\u4e86\u7ea6\u56db\u5206\u4e4b\u4e00\uff0c\u800c\u7092\u4eba\u5219\u66f4\u662f\u7a00\u677e\u5e73\u5e38\u7684\u4e8b\u60c5\u30022013\u5e74\u590f\u5929\uff0c\u8bfa\u534e\u5f00\u9664\u4e86\u53c2\u4e0e\u4ee3\u6587\u5b66\u672f\u9020\u5047\u7684\u5458\u5de5\u3002\u7136\u800c\uff0c\u65e5\u672c\u76d1\u7ba1\u673a\u6784\u6ca1\u6709\u56e0\u6b64\u800c\u624b\u8f6f\uff0c3\u6708\u5373\u5bf9\u8bfa\u534e\u516c\u53f8\u53ca\u9ad8\u7ba1\u63d0\u8d77\u5211\u4e8b\u8bc9\u8bbc\uff0c\u79f0\u8bfa\u534e\u4f7f\u7528\u865a\u5047\u6570\u636e\u4fc3\u9500\u836f\u7269\u3002<\/p>\n<p>\u9664\u4e86\u5f00\u9664\u7ecf\u7406\uff0c\u8bfa\u534e\u8868\u793a\u5c06\u91c7\u53d6\u4e00\u5207\u884c\u52a8\u53cd\u5bf9\u516c\u53f8\u5458\u5de5\u53c2\u4e0e\u767d\u8840\u75c5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5b66\u672f\u4e0d\u7aef\u884c\u4e3a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An interim report from the University of Tokyo Hospital found that Novartis inappropriately received data on patients participating in a trial of the company&#8217;s leukaemia drug Tasigna (nilotinib). &#8221; The [&hellip;]<\/p>\n","protected":false},"author":951,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[3,5],"tags":[9,13,17],"class_list":["post-538","post","type-post","status-publish","format-standard","hentry","category-hospital-news","category-pharmaceutical-company-news","tag-corruption","tag-drug-saftey","tag-government-supervision"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/951"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=538"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/538\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}